Carl Zeiss Meditec dividend and valuation
Valuation
Carl Zeiss Meditec paid €0.55 per share in dividends over the last 12 months (yield 1.6%). Last ex-dividend date: March 27, 2026. The P/E ratio is 25.2. The average price target of 15 analysts is €26.93.
Data as of November 15, 2026
Carl Zeiss Meditec compared with similar companies
Carl Zeiss Meditec's P/E (trailing 12 months): 25.2, in line with the median of a group of 9 similar companies (25.2).
| Metric | Carl Zeiss Meditec | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 25.2 | 25.2 | 19.9 – 34.4 | Middle |
| Forward P/E | 24.0 | 20.4 | 15.6 – 30.0 | Middle |
| EV/EBITDA | 16.5 | 13.5 | 10.1 – 17.7 | Middle |
| Price/book | 1.46 | 3.34 | 2.20 – 5.20 | Low |
| Price/sales | 1.40 | 1.98 | 1.43 – 3.41 | Low |
| Gross margin | 51.6% | 51.6% | 36.4% – 59.1% | Middle |
| Operating margin | 7.2% | 13.7% | 7.2% – 17.6% | Middle |
| Net margin | 5.6% | 6.0% | 5.2% – 11.0% | Middle |
| ROE | 4.5% | 11.5% | 6.1% – 24.9% | Low |
| Debt/equity | 0.28 | 0.35 | 0.23 – 1.04 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Carl Zeiss Meditec: valuation over time
On the latest fiscal year's earnings (2025), Carl Zeiss Meditec's P/E today is 21.5, below the median of its last 10 fiscal years (34.0; between 25.5 and 78.9 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (1.6%) is above the median of the last 10 fiscal years (0.9%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| Sep 2025 | €42.16 | €1.61 | 26.1 | €0.55 | 1.3% |
| Sep 2024 | €71.15 | €2.01 | 35.4 | €0.60 | 0.8% |
| Sep 2023 | €82.82 | €3.25 | 25.5 | €1.10 | 1.3% |
| Sep 2022 | €107.45 | €3.29 | 32.7 | €1.10 | 1.0% |
| Sep 2021 | €166.05 | €2.64 | 62.9 | €0.90 | 0.5% |
| Sep 2020 | €108.00 | €1.37 | 78.9 | €0.50 | 0.5% |
| Sep 2019 | €104.60 | €1.79 | 58.6 | €0.65 | 0.6% |
| Sep 2018 | €72.50 | €1.41 | 51.3 | €0.55 | 0.8% |
| Sep 2017 | €44.17 | €1.57 | 28.1 | €0.55 | 1.2% |
| Sep 2016 | €34.03 | €1.21 | 28.1 | €0.42 | 1.2% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €3.06B
- Enterprise value
- €3.59B
- PEG
- 1.20
- EV/revenue
- 1.64
Profitability and growth
- ROA
- 2.7%
- ROIC
- 3.5%
- Revenue growth (year over year)
- 2.4%
- Earnings growth (year over year)
- 97.5%
Financial health
- Total cash
- €23.9M
- Total debt
- €580.95M
- Current ratio
- 2.43
- Quick ratio
- 1.27
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- €0.55
- Dividend yield
- 1.6%
- Payout ratio
- 39.6%
- Ex-dividend date
- March 27, 2026
Analysts and estimates
- Average price target
- €26.93
- Median price target
- €26.50
- High price target
- €35.00
- Low price target
- €18.10
- Analysts with a price target
- 15
- Forward EPS
- €1.46
- EPS estimate, current year
- €1.34
Shares and trading
- Beta
- 1.35
- Average volume
- 165.1K
- Shares outstanding
- 87.54M
- Float
- 34.19M
- Institutional ownership
- 19.9%
- Insider ownership
- 59.1%
